Contact Us Careers
English 简体中文 繁體中文
EN 中文 繁體

B细胞淋巴瘤

"Anti-cancer Special Force vNKT" is emerging as a rising star in China's immunology community.

Lung Cancer Stomach Cancer Hepatobiliary and Pancreatic Cancers Intestine Cancer Breast Cancer B-cell lymphoma Cervical Cancer Other Solid Tumors
Home > Oncology Clinical Research > B细胞淋巴瘤

B细胞淋巴瘤

How long does cell immunotherapy need to be continued for to be considered as approaching the goal of cure?

Analyze a patient with advanced colon cancer who has been followed up for over 6 years ...
View More+

After 3 surgeries and 2 rounds of chemotherapy, frequent recurrences left him in unbearable pain. This is the personal account of a bladder cancer patient

After multiple rounds of chemotherapy with different regimens failed to resolve the recurrence issue, Mr. Xi's condition ... ...
View More+

vNKT cells combined with targeted drugs can prolong the duration of resistance to targeted drugs, achieving a breakthrough in survival time of over 6 years!

This personalized treatment plan has significantly extended Ms. Bu's survival period beyond 6 years! ...
View More+
About Lehe
Corporate Culture Founder's Introduction Lehe News Story of Lehe Science Popularization Academic Literature
New Medical Services
Second Consultation Rehabilitation and Wellness Elite Care
Oncology Clinical Research
Lung Cancer Stomach Cancer Hepatobiliary and Pancreatic Cancers Intestine Cancer Breast Cancer B-cell lymphoma Cervical Cancer Other Solid Tumors
Chronic Disease Research
Hypertension Diabetes Obesity Immune Diseases Degenerative Diseases Chronic Inflammation Others

Contact Us

Address: Room 1101 (Unit 101), 11th Floor, Building 1, No. 7 Courtyard, Kexueyuan Road, Life Science Park, Changping District, Beijing
Phone：010-8265 9866
Email：lehemedneo@hotmail.com

微信
抖音
哔哩哔哩
头条
Copyright©2022 Beijing Lehe New Medical Clinic Co., Ltd. All Rights Reserved ICP: 京ICP备2025148232号 京公网安备11011402054997号 Privacy Policy